Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study

Paolo Baili, Francesca Di Salvo, Francesco De Lorenzo, Francesco Maietta, Carmine Pinto, Vera Rizzotto, Massimo Vicentini, Paolo Giorgi Rossi, Rosario Tumino, Patrizia Concetta Rollo, Giovanna Tagliabue, Paolo Contiero, Pina Candela, Tiziana Scuderi, Elisabetta Iannelli, Stefano Cascinu, Fulvio Aurora, Roberto Agresti, Alberto Turco, Milena SantElisabetta Meneghini, Andrea Micheli

Research output: Contribution to journalArticle

Abstract

PURPOSE: To illustrate the out-of-pocket (OOP) costs incurred by a population-based group of patients from 5 to 10 years since their cancer diagnosis in a country with a nationwide public health system.

METHODS: Interviews on OOP costs to a sample of 5-10 year prevalent cases randomly extracted from four population-based cancer registries (CRs), two in the north and two in the south of Italy. The patients' general practitioners (GPs) gave assurance about the patient's physical and psychological condition for the interview. A zero-inflated negative binomial model was used to analyze OOP cost determinants.

RESULTS: Two hundred six cancer patients were interviewed (48 % of the original sample). On average, a patient in the north spent €69 monthly, against €244 in the south. The main differences are for transport, room, and board (TRB) to reach the hospital and/or the cancer specialist (north €0; south €119). Everywhere, OOP costs without TRB costs were higher for patients with a low quality of life.

CONCLUSIONS: Despite the limited participation, our study sample's characteristics are similar to those of the Italian cancer prevalence population, allowing us to generalize the results. The higher OOP costs in the south may be due to the scarcity of oncologic structures, obliging patients to seek assistance far from their residence. Implications for cancer survivors Cancer survivors need descriptive studies to show realistic data about their status. Future Italian and European descriptive studies on cancer survivorship should be based on population CRs and involve GPs in order to approach the patient at best.

Original languageEnglish
Pages (from-to)2225-33
Number of pages9
JournalSupportive Care in Cancer
Volume24
Issue number5
DOIs
Publication statusPublished - May 2016

Fingerprint

Health Expenditures
Survivors
Population
Neoplasms
General Practitioners
Registries
Psychological Interviews
Cancer Care Facilities
Statistical Models
Population Groups
Italy
Survival Rate
Public Health
Quality of Life
Interviews
Costs and Cost Analysis

Keywords

  • Aged
  • Aged, 80 and over
  • Female
  • Health Expenditures
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Neoplasms
  • Quality of Life
  • Surveys and Questionnaires
  • Survivors
  • Time Factors
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis : an Italian population-based study. / Baili, Paolo; Di Salvo, Francesca; De Lorenzo, Francesco; Maietta, Francesco; Pinto, Carmine; Rizzotto, Vera; Vicentini, Massimo; Giorgi Rossi, Paolo; Tumino, Rosario; Rollo, Patrizia Concetta; Tagliabue, Giovanna; Contiero, Paolo; Candela, Pina; Scuderi, Tiziana; Iannelli, Elisabetta; Cascinu, Stefano; Aurora, Fulvio; Agresti, Roberto; Turco, Alberto; Sant, Milena; Meneghini, Elisabetta; Micheli, Andrea.

In: Supportive Care in Cancer, Vol. 24, No. 5, 05.2016, p. 2225-33.

Research output: Contribution to journalArticle

Baili, P, Di Salvo, F, De Lorenzo, F, Maietta, F, Pinto, C, Rizzotto, V, Vicentini, M, Giorgi Rossi, P, Tumino, R, Rollo, PC, Tagliabue, G, Contiero, P, Candela, P, Scuderi, T, Iannelli, E, Cascinu, S, Aurora, F, Agresti, R, Turco, A, Sant, M, Meneghini, E & Micheli, A 2016, 'Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study', Supportive Care in Cancer, vol. 24, no. 5, pp. 2225-33. https://doi.org/10.1007/s00520-015-3019-8
Baili, Paolo ; Di Salvo, Francesca ; De Lorenzo, Francesco ; Maietta, Francesco ; Pinto, Carmine ; Rizzotto, Vera ; Vicentini, Massimo ; Giorgi Rossi, Paolo ; Tumino, Rosario ; Rollo, Patrizia Concetta ; Tagliabue, Giovanna ; Contiero, Paolo ; Candela, Pina ; Scuderi, Tiziana ; Iannelli, Elisabetta ; Cascinu, Stefano ; Aurora, Fulvio ; Agresti, Roberto ; Turco, Alberto ; Sant, Milena ; Meneghini, Elisabetta ; Micheli, Andrea. / Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis : an Italian population-based study. In: Supportive Care in Cancer. 2016 ; Vol. 24, No. 5. pp. 2225-33.
@article{33c5dc6bc6dd4b25ba5ed3374fb6f838,
title = "Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study",
abstract = "PURPOSE: To illustrate the out-of-pocket (OOP) costs incurred by a population-based group of patients from 5 to 10 years since their cancer diagnosis in a country with a nationwide public health system.METHODS: Interviews on OOP costs to a sample of 5-10 year prevalent cases randomly extracted from four population-based cancer registries (CRs), two in the north and two in the south of Italy. The patients' general practitioners (GPs) gave assurance about the patient's physical and psychological condition for the interview. A zero-inflated negative binomial model was used to analyze OOP cost determinants.RESULTS: Two hundred six cancer patients were interviewed (48 {\%} of the original sample). On average, a patient in the north spent €69 monthly, against €244 in the south. The main differences are for transport, room, and board (TRB) to reach the hospital and/or the cancer specialist (north €0; south €119). Everywhere, OOP costs without TRB costs were higher for patients with a low quality of life.CONCLUSIONS: Despite the limited participation, our study sample's characteristics are similar to those of the Italian cancer prevalence population, allowing us to generalize the results. The higher OOP costs in the south may be due to the scarcity of oncologic structures, obliging patients to seek assistance far from their residence. Implications for cancer survivors Cancer survivors need descriptive studies to show realistic data about their status. Future Italian and European descriptive studies on cancer survivorship should be based on population CRs and involve GPs in order to approach the patient at best.",
keywords = "Aged, Aged, 80 and over, Female, Health Expenditures, Humans, Italy, Male, Middle Aged, Neoplasms, Quality of Life, Surveys and Questionnaires, Survivors, Time Factors, Journal Article, Research Support, Non-U.S. Gov't",
author = "Paolo Baili and {Di Salvo}, Francesca and {De Lorenzo}, Francesco and Francesco Maietta and Carmine Pinto and Vera Rizzotto and Massimo Vicentini and {Giorgi Rossi}, Paolo and Rosario Tumino and Rollo, {Patrizia Concetta} and Giovanna Tagliabue and Paolo Contiero and Pina Candela and Tiziana Scuderi and Elisabetta Iannelli and Stefano Cascinu and Fulvio Aurora and Roberto Agresti and Alberto Turco and Milena Sant and Elisabetta Meneghini and Andrea Micheli",
year = "2016",
month = "5",
doi = "10.1007/s00520-015-3019-8",
language = "English",
volume = "24",
pages = "2225--33",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis

T2 - an Italian population-based study

AU - Baili, Paolo

AU - Di Salvo, Francesca

AU - De Lorenzo, Francesco

AU - Maietta, Francesco

AU - Pinto, Carmine

AU - Rizzotto, Vera

AU - Vicentini, Massimo

AU - Giorgi Rossi, Paolo

AU - Tumino, Rosario

AU - Rollo, Patrizia Concetta

AU - Tagliabue, Giovanna

AU - Contiero, Paolo

AU - Candela, Pina

AU - Scuderi, Tiziana

AU - Iannelli, Elisabetta

AU - Cascinu, Stefano

AU - Aurora, Fulvio

AU - Agresti, Roberto

AU - Turco, Alberto

AU - Sant, Milena

AU - Meneghini, Elisabetta

AU - Micheli, Andrea

PY - 2016/5

Y1 - 2016/5

N2 - PURPOSE: To illustrate the out-of-pocket (OOP) costs incurred by a population-based group of patients from 5 to 10 years since their cancer diagnosis in a country with a nationwide public health system.METHODS: Interviews on OOP costs to a sample of 5-10 year prevalent cases randomly extracted from four population-based cancer registries (CRs), two in the north and two in the south of Italy. The patients' general practitioners (GPs) gave assurance about the patient's physical and psychological condition for the interview. A zero-inflated negative binomial model was used to analyze OOP cost determinants.RESULTS: Two hundred six cancer patients were interviewed (48 % of the original sample). On average, a patient in the north spent €69 monthly, against €244 in the south. The main differences are for transport, room, and board (TRB) to reach the hospital and/or the cancer specialist (north €0; south €119). Everywhere, OOP costs without TRB costs were higher for patients with a low quality of life.CONCLUSIONS: Despite the limited participation, our study sample's characteristics are similar to those of the Italian cancer prevalence population, allowing us to generalize the results. The higher OOP costs in the south may be due to the scarcity of oncologic structures, obliging patients to seek assistance far from their residence. Implications for cancer survivors Cancer survivors need descriptive studies to show realistic data about their status. Future Italian and European descriptive studies on cancer survivorship should be based on population CRs and involve GPs in order to approach the patient at best.

AB - PURPOSE: To illustrate the out-of-pocket (OOP) costs incurred by a population-based group of patients from 5 to 10 years since their cancer diagnosis in a country with a nationwide public health system.METHODS: Interviews on OOP costs to a sample of 5-10 year prevalent cases randomly extracted from four population-based cancer registries (CRs), two in the north and two in the south of Italy. The patients' general practitioners (GPs) gave assurance about the patient's physical and psychological condition for the interview. A zero-inflated negative binomial model was used to analyze OOP cost determinants.RESULTS: Two hundred six cancer patients were interviewed (48 % of the original sample). On average, a patient in the north spent €69 monthly, against €244 in the south. The main differences are for transport, room, and board (TRB) to reach the hospital and/or the cancer specialist (north €0; south €119). Everywhere, OOP costs without TRB costs were higher for patients with a low quality of life.CONCLUSIONS: Despite the limited participation, our study sample's characteristics are similar to those of the Italian cancer prevalence population, allowing us to generalize the results. The higher OOP costs in the south may be due to the scarcity of oncologic structures, obliging patients to seek assistance far from their residence. Implications for cancer survivors Cancer survivors need descriptive studies to show realistic data about their status. Future Italian and European descriptive studies on cancer survivorship should be based on population CRs and involve GPs in order to approach the patient at best.

KW - Aged

KW - Aged, 80 and over

KW - Female

KW - Health Expenditures

KW - Humans

KW - Italy

KW - Male

KW - Middle Aged

KW - Neoplasms

KW - Quality of Life

KW - Surveys and Questionnaires

KW - Survivors

KW - Time Factors

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1007/s00520-015-3019-8

DO - 10.1007/s00520-015-3019-8

M3 - Article

C2 - 26573280

VL - 24

SP - 2225

EP - 2233

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 5

ER -